Navigation Links
RU-486, The Abortion Pill, May Quell The Breast Cancer Gene

The abortion drug RU-486 was used by scientists in mice that were bred with a breast cancer gene. The drug turned beneficial in warding off potential tumors.//

This is thought to have been possible due to the abortion drug, known to inhibit the hormone, progesterone. This is indeed a teaser to researchers to evolve a safe version of the hormone blocker as an option for women carrying the breast cancer gene.

Cell biologist Eva Lee of the University of California, Irvine, who led the research said, 'All of us have to be cautious. But I do think if there is a better anti-progesterone available, hopefully there will be other options in the future for these women.'

This has certainly raised the curiosity of the scientists who could translate the success in the mouse model and reflect it on better drugs for humans. Once scientists are able to nail how BRCA1 actually causes tumors, it will enable the knowledge to tide over the bad effects of BRCA1.

As part of the research, Lee and colleagues nurtured mice whose mammary glands accommodated only the BRCA1 mutation. Scientists actually found that the bad gene, which caused breast cancers, was also responsible in the breast tissue portraying high levels of progesterone receptors. The final proof came from RU-486, also known as mifepristone. It triggers human abortions by inhibiting progesterone, a hormone that is extremely important to support pregnancy.

In the experiment, Lee implanted a pellet of RU -486 in some of the cancer-susceptible mice; the drug would gradually be released into their bodies, over a period of two months. The finding revealed that within 8 months of age, the mice that were not treated, developed tumors. But the mice which were given RU-486 had not developed tumors at the end of the year. But researchers left a warning, that prolonged use of RU-486 is not recommended. Other varieties of progesterone-blockers which are safe for prolonged use are in the process of being developed.

Related medicine news :

1. Abortion Pill approved by FDA
2. Abortion made easy pill causes alarm in state
3. Treatment for fibroids with "Abortion Pill"
4. Abortion may cause mental illness
5. Abortion Does Not Increase Risk Of Depression In Women
6. Teenage Girls May Not Need Parents Consent For Abortion
7. Botched Abortions Trigger Concern Over Legal Ambiguity In Britain
8. Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved
9. Mother Claims Hefty Compensation For Failed Abortion Of Twins
10. Abortions does not increase risk of breast cancer
11. Bill to Ban Abortion In Indiana Introduced
Post Your Comments:

(Date:11/30/2015)... ... 30, 2015 , ... California-based i2i Systems, a pioneer defining ... Michigan-based Family Health Center (FHC) has selected i2iTracks as their population health management ... the largest Affordable Care Act grant for Federally Qualified Health Centers in the ...
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... two new additions to its industry-leading suite of automated breast density assessment ... North America (RSNA) meeting, November 29-December 4, 2015 (South Hall booth #2377). ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... 2015 , ... Scott Newman MD, FACS of New York’s ... surgeons in the New York City area to utilize the new, non-invasive SculpSure™ ... laser treatment for fat loss in the abdomen, flanks, and other areas that ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... healthcare professionals worldwide today released the results of a survey of educational needs ... and Africa found a growing global demand for high quality online and face-to-face ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Calif. , Nov. 30, 2015 /PRNewswire/ ... the norm in U.S. medical imaging is ... increasingly popular accountable care payer-provider contracts are ... and, in their wake, alter provider-vendor relationships. ... payments will push forward new purchasing frameworks ...
(Date:11/30/2015)... JERUSALEM , Nov. 30, 2015 Oramed ... company focused on the development of oral drug delivery ... investment agreements valued at up to $50,000,000 with Hefei Tianhui Incubator of ... Oramed,s oral insulin capsule, ORMD-0801, in China ... Macau . The agreements were signed ...
(Date:11/30/2015)... N.H. , Nov. 30, 2015 ... that it will feature its latest solutions for ... early identification of cancer at the Radiological Society ... Chicago from November 29 ... recent product advances including iReveal®, an automated breast ...
Breaking Medicine Technology: